Abstract
Vaults are naturally occurring nanoparticles found widely in eukaryotes. The particles can be produced in large quantities and are assembled in situ from multiple copies of the single structural protein following expression. Using molecular engineering, recombinant vaults can be functionally modified and targeted, and their contents can be controlled by packaging. Here, we review the development of engineered vaults as a platform for a wide variety of therapeutic applications and we examine future directions for this unique nanoparticle system.
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Animals
-
Drug Carriers / chemistry
-
Drug Carriers / metabolism
-
Drug Carriers / therapeutic use
-
Humans
-
Immunotherapy
-
Nanotechnology / methods*
-
Protein Engineering
-
Vaccines / chemistry
-
Vaccines / genetics
-
Vaccines / metabolism
-
Vaccines / therapeutic use
-
Vault Ribonucleoprotein Particles* / chemistry
-
Vault Ribonucleoprotein Particles* / genetics
-
Vault Ribonucleoprotein Particles* / metabolism
-
Vault Ribonucleoprotein Particles* / therapeutic use
Substances
-
Drug Carriers
-
Vaccines
-
Vault Ribonucleoprotein Particles